CCGB(SZ:300138) Xin Lang Cai Jing·2026-01-16 03:02Group 1 - The core viewpoint of the news is that Morning Light Bio has shown a mixed performance in stock price and financial results, with a notable increase in net profit despite a decline in revenue [1][2]. - As of January 16, Morning Light Bio's stock price increased by 2.00% to 13.75 CNY per share, with a total market capitalization of 6.643 billion CNY [1]. - The company has experienced a year-to-date stock price increase of 10.80%, with a 4.64% rise over the last five trading days and a 7.25% increase over the last 20 days, although it has seen a 5.37% decline over the last 60 days [1]. Group 2 - For the period from January to September 2025, Morning Light Bio reported a revenue of 5.047 billion CNY, a year-on-year decrease of 3.41%, while the net profit attributable to shareholders increased by 385.30% to 304 million CNY [2]. - The company has distributed a total of 516 million CNY in dividends since its A-share listing, with 213 million CNY distributed in the last three years [3]. - As of September 30, 2025, the number of shareholders increased by 6.72% to 16,700, while the average circulating shares per person decreased by 6.30% to 23,895 shares [2][3].